Letter to the Editor on: Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3602-3603
DOI: 10.1111/jgh.70728 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 03.09.2026. Verfasst von Asad Ali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Sheikh Khalifa Bin Zayed Al Nayhan Medical and Dental College, Lahore, Pakistan. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Sheikh Khalifa Bin Zayed Al Nayhan Medical and Dental College, Lahore, Pakistan.
ORCID-Profile: Asad Ali, Malik Zubair Hussain
Zitieren
APA
Ali, A., & Hussain, M. Z. (2026). Letter to the Editor on: Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Journal of Gastroenterology and Hepatology, 41(11), 3602-3603. https://doi.org/10.1111/jgh.70728
Vancouver
Ali A, Hussain MZ. Letter to the Editor on: Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials. Journal of Gastroenterology and Hepatology. 2026;41(11):3602-3603. doi:10.1111/jgh.70728
BibTeX
@article{Ali2026,
author = {Ali, Asad and Hussain, Malik Zubair},
title = {Letter to the Editor on: Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {11},
pages = {3602--3603},
doi = {10.1111/jgh.70728}
}
EUVIMED